| ST | esotropia; scala tympani; scaphotrapezoid; sclerotherapy; sedimentation time; semitendinosus; sensor... |
|---|---|
| STP | phenol-preferring sulfotransferase; scientifically treated petroleum; sodium thiopental; standard te... |
| SGP | serine glycerophosphatide; sialoglycoprotein; Society of General Physiologists; soluble glycoprotein... |
| SCMCT | Sperm Cervical Mucus Contact Test |
| CM | California mastitis [test]; calmodulin; capreomycin; carboxymethyl; cardiac murmur; cardiac muscle; ... |
| CM | Cervical mucus |
|---|---|
| SCMPT | sperm cervical mucus penetration test |
| ST | Sulfotransferase |
| AST | Aryl sulfotransferase |
| CST | Cerebroside sulfotransferase |
| mucus glycoprotein sulfotransferase | <enzyme> Specific for gastric mucus sulfation Registry number: EC 2.8.2.- Synonym: mucus gp sulfotransferase (26 Jun 1999) |
|---|
| glairy mucus | A thick nasal secretion. Synonym: glairy mucus. Origin: L. Phlegm or thick mucous secretion (05 Mar 2000) |
|---|---|
| cervix mucus | A slightly alkaline secretion of the endocervical glands. The consistency and amount are dependent on the physiological hormone changes in the menstrual cycle. It contains the glycoprotein mucin, amino acids, sugar, enzymes, and electrolytes, with a water content up to 90%. The mucus is a useful protection against the ascent of bacteria and sperm into the uterus. (12 Dec 1998) |
| colitis, mucus | A common gastrointestinal disorder characterised by abdominal pain, bloating, mucous in stools, and irregular bowel habits with alternating diarrhoea and constipation, symptoms that tend to be chronic and wax and wane over the years. Although mucus colitis can cause chronic recurrent discomfort, it appears to be an abnormal condition of gut contractions (motility) and does not lead to any serious organ problems. Diagnosis usually involves excluding other illnesses. Treatment is directed toward relief of symptoms and includes high fibre diet, exercise, relaxation techniques, avoidance of caffeine, milk products and sweeteners, and medications. Alternative names include irritable bowel syndrome, spastic colitis and nervous colon syndrome. (12 Dec 1998) |
| mucus | The free slime of the mucous membranes, composed of secretion of the glands, along with various inorganic salts, desquamated cells and leucocytes. (18 Nov 1997) |
| mucus colitis | A common gastrointestinal disorder characterised by abdominal pain, bloating, mucous in stools, and irregular bowel habits with alternating diarrhoea and constipation, symptoms that tend to be chronic and wax and wane over the years. Although mucus colitis can cause chronic recurrent discomfort, it appears to be an abnormal condition of gut contractions (motility) and does not lead to any serious organ problems. Diagnosis usually involves excluding other illnesses. Treatment is directed toward relief of symptoms and includes high fibre diet, exercise, relaxation techniques, avoidance of caffeine, milk products and sweeteners, and medications. Alternative names include irritable bowel syndrome, spastic colitis and nervous colon syndrome. (12 Dec 1998) |
| mucus impaction | Filling of the proximal bronchi, and also the bronchioles, with mucus. (05 Mar 2000) |
| a1-acid glycoprotein | <biology> Plasma protein of mammals and birds, 38% carbohydrate. In humans a single chain glycoprotein of 39 kD. Increased levels are associated with inflammation, pregnancy and various diseases. (18 Nov 1997) |
| acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase | <enzyme> Forms oligosaccharide core class 3 (glcnac beta 1-3galnac) in mucins and various glycoproteins Registry number: EC 2.4.1.147 Synonym: udp-glcnac-galnac-r beta 3-acetylglucosaminyltransferase, agggag-transferase (26 Jun 1999) |
| amyloidogenic glycoprotein | <protein> An integral membrane glycoprotein of the brain and related to the Drosophila vnd gene product. A precursor of _ amyloid, that accumulates in Alzheimer's disease and Down's syndrome. See: amyloid precursor protein. (18 Nov 1997) |
| b2-glycoprotein II | <enzyme> A glycine-rich, heat-labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor b is converted by factor d to c3 convertase. Registry number: EC 3.4.21.47 (12 Dec 1998) |
| beta-1,3-galactosyl-0-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase | <enzyme> Capable of adding a glcnac residue to g1cnacman(3)g1cnac; from mung bean seedlings Registry number: EC 2.4.1.146 Synonym: n-acetylglucosaminyltransferase II, gal3-(glcnac6)galnac-mucin (glcnac--gal)3-glcnactransferase (26 Jun 1999) |
| beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-acetylglucosaminyl transferase | <enzyme> With EC 2.4.1.148 this is called beta6-glcnac-transferase b Registry number: EC 2.4.1.102 Synonym: gal3-galnac-mucin-6-glcnac transferase, udp-glcnac-gal1-3galnac-r-(glcnac to galnac)-beta1-6glcnac transferase, core 2 glcnac transferase, core 2-n-acetylglucosaminyltransferase, core 2 beta6-gn-t (26 Jun 1999) |
| beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase | <enzyme> Induced in preneoplastic stage of liver carcinogenesis promoted by orotic acid in rats; adds "bisecting n-acetylglucosaminyl residue in beta 1,4 linkage to the beta-linked mannose of the core of asparagine-linked oligosaccharides Registry number: EC 2.4.1.144 Synonym: n-acetylglucosaminyltransferase III, udpgnac-glycopeptide beta4-n-acetylglucosaminyl transferase III, udpgnac-magtransferase III, udp-n-acetylglucosamine-beta-d-mannoside beta-1,4-n-acetylglucosaminyltransferase III (26 Jun 1999) |
| carbohydrate-deficient glycoprotein syndrome | <syndrome> An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors. (12 Dec 1998) |
| variable surface glycoprotein | <protein> One of a battery of antigenicdeterminants expressed by a microorganism to elude immune detection. (09 Oct 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|